Kidney allograft donor ABCB1 pharmacogenotype predicts long term vascular fibrous thickening and tubular atrophy – pharmacogenomic analysis of a prospective Australian cohort
Joshua Lawrence Lee (AU)
Clinical pharmacology
Chairs
Teun van Gelder (NL)
· Steven Ivulich (AU)
Presentations
Oral Presentation
Mini-Oral Presentation
Clinical significance of intra-patient tacrolimus variability and tacrolimus exposure in older kidney transplant recipients
Minyu Kang (KR)
Mechanism study of Tacrolimus inhibiting FXR mediated toxicity of renal tubular epithelial cells
Zhaofeng Liu (CN)
BAP-Tac (BuccomucoAdhesive Patch-based Tacrolimus) Delivery System: The Next-Generation of Tacrolimus Administration
Smita Pattanaik (IN)
Hidden Interaction: Dulaglutide Significantly Alters Immunosuppressant Pharmacokinetics After Kidney Transplantation
Nuria Montero (ES)
Early Post-Transplant Torque Teno Virus (TTV) Load Dynamics Predict Infection Risk and Reflect Immune Alterations in Kidney Transplant Recipients
Tarun Kumar (IN)